PubRank

Claire Julian-Reynier

Author PubWeight™ 28.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet 2010 1.47
2 Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet 2002 1.26
3 Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet 2011 1.23
4 Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view. Psychooncology 2010 1.18
5 Assessing educational priorities in genetics for general practitioners and specialists in five countries: factor structure of the Genetic-Educational Priorities (Gen-EP) scale. Genet Med 2008 1.14
6 Patients' characteristics and rate of Internet use to obtain cancer information. J Public Health (Oxf) 2006 1.08
7 Diffusion of information about genetic risk within families. Neuromuscul Disord 1996 1.05
8 Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients. Qual Life Res 2006 1.00
9 Educational priorities and current involvement in genetic practice: a survey of midwives in the Netherlands, UK and Sweden. Midwifery 2008 0.98
10 Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing. Int J Technol Assess Health Care 2003 0.98
11 Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. Eur J Cancer 2006 0.97
12 Consent for biobanking: assessing the understanding and views of cancer patients. J Natl Cancer Inst 2010 0.95
13 Testing participation in BRCA1/2-positive families: initiator role of index cases. Genet Test 2003 0.90
14 Genetic education and nongenetic health professionals: educational providers and curricula in Europe. Genet Med 2005 0.88
15 Behavioral and economic impact of a familial history of cancers. Fam Cancer 2005 0.85
16 Testing the children: do non-genetic health-care providers differ in their decision to advise genetic presymptomatic testing on minors? A cross-sectional study in five countries in the European Union. Genet Test Mol Biomarkers 2009 0.85
17 International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis 2007 0.83
18 "They should take time": disclosure of clinical trial results as part of a social relationship. Soc Sci Med 2012 0.83
19 Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study. Eur J Hum Genet 2012 0.82
20 Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Eur J Hum Genet 2011 0.82
21 General practitioner management of genetic aspects of a cardiac disease: a scenario-based study to anticipate providers' practices. J Community Genet 2010 0.82
22 Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities. J Community Genet 2013 0.81
23 Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation. J Clin Epidemiol 2002 0.80
24 [Targeted chemotherapy for breast cancer: patients perception of the use of tumor gene profiling approaches to better adapt treatments]. Med Sci (Paris) 2012 0.79
25 Contributing to research via biobanks: what it means to cancer patients. Health Expect 2012 0.78
26 Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends? Fam Cancer 2013 0.78
27 Patients' regrets after participating in a randomized controlled trials depended on their involvement in the decision making. J Clin Epidemiol 2012 0.78
28 Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure? Psychooncology 2013 0.78
29 Development of a scale for assessing respondents' perceptions of health research questionnaires (the REP-HQ Scale). J Clin Epidemiol 2012 0.77
30 Cancer genetic testing: current and emerging issues. Psychooncology 2008 0.77
31 Cancer survivors: familial risk perception and management advice given to their relatives. Fam Cancer 2011 0.76
32 Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women. BMC Womens Health 2013 0.75
33 Congress report of the seventh international meeting on psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer (HBOC) and hereditary non-polyposis colorectal cancer (HNPCC). Psychooncology 2002 0.75
34 [Human, economics and social sciences: rebounds of ideas on genomics and clinical trials]. Med Sci (Paris) 2012 0.75
35 Preferences of older adults with cancer for involvement in decision-making about research participation. J Am Geriatr Soc 2014 0.75
36 [Perception by cancer patients of biomedical research in the era of large-scale biobanking]. Med Sci (Paris) 2012 0.75
37 Communicating familial risks: individual and community issues involved in cancer genetics. Community Genet 2003 0.75
38 [How to share results of clinical trials with study participants?]. Med Sci (Paris) 2012 0.75
39 Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort). Fam Cancer 2015 0.75
40 Self-management strategies adopted by breast cancer survivors to improve their adherence to tamoxifen. Breast J 2012 0.75
41 Transparency in the presentation of trial results may not increase patients' trust in medical researchers. Clin Trials 2011 0.75
42 [The supply of breast/ovarian cancer genetic susceptibility tests in France]. Med Sci (Paris) 2004 0.75